{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:57Z","timestamp":1786422717746,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]},{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]},{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]},{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]},{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]},{"name":"French Health Ministry","award":["RESPIR-2022-005"],"award-info":[{"award-number":["RESPIR-2022-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-026-03413-3","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:32:47Z","timestamp":1780702367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Access to renal function information to improve pharmaceutical care in direct oral anticoagulant users: a cluster randomized trial protocol"],"prefix":"10.1186","volume":"27","author":[{"given":"Imane","family":"Badran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Clarenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Mongaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Ohl-Hurtaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Slimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1","key":"3413_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13643-022-02098-w","volume":"11","author":"C Khouja","year":"2022","unstructured":"Khouja C, Brunton G, Richardson M, Stokes G, Blanchard L, Burchett H, Khatwa M, Walker R, Wright K, Sowden A, Thomas J. Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences. Syst Rev. 2022;11(1):232. https:\/\/doi.org\/10.1186\/s13643-022-02098-w","journal-title":"Syst Rev"},{"issue":"13","key":"3413_CR2","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden A. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges. J Am Heart Assoc. 2020;9(13):e017559. https:\/\/doi.org\/10.1161\/JAHA.120.017559.","journal-title":"J Am Heart Assoc"},{"key":"3413_CR3","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. [Rapport d\u2019\u00e9valuation des m\u00e9dicaments anticoagulants oraux]. Avialable online: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/201802\/rapport_reev_aco_cteval234_2018-02-09_15-38-37_999.pdf. (accessed 2nd September, 2025)."},{"issue":"1","key":"3413_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bcp.15510","volume":"89","author":"ML Laroche","year":"2023","unstructured":"Laroche ML, Gautier S, Polard E, Rabier MB, Chouchana L, Lebrun-Vignes B, Faillie JL, Petitpain N, Lagarce L, Jonville-Bera AP, IATROSTAT study group. Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT). Br J Clin Pharmacol. 2023;89(1):390\u2013400. https:\/\/doi.org\/10.1111\/bcp.15510.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"3413_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.revmed.2020.05.026","volume":"41","author":"C Hoffmann","year":"2020","unstructured":"Hoffmann C, Leven C, Le Mao R, De Moreuil C, Lacut K. Direct oral anticoagulants: In which indications? Which one to prescribe? For or against their use in frail patients and in atypical cases? Which monitoring and management haemorrhage complications? Rev Med Interne. 2020;41(9):598\u2013606. https:\/\/doi.org\/10.1016\/j.revmed.2020.05.026. [French].","journal-title":"Rev Med Interne"},{"issue":"10","key":"3413_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40266-021-00883-1","volume":"38","author":"M Cavillon Decaestecker","year":"2021","unstructured":"Cavillon Decaestecker M, Ferret L, Decaestecker K, Gautier S, Verdun S, Tsogli ES. Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over. Drugs Aging. 2021;38(10):939\u201350. https:\/\/doi.org\/10.1007\/s40266-021-00883-1.","journal-title":"Drugs Aging"},{"issue":"8","key":"3413_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/clc.23196","volume":"42","author":"V Aursulesei","year":"2019","unstructured":"Aursulesei V, Costache II. Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol. 2019;42(8):774\u201382. https:\/\/doi.org\/10.1002\/clc.23196.","journal-title":"Clin Cardiol"},{"key":"3413_CR8","unstructured":"Arr\u00eat\u00e9 du 28. novembre 2016 relatif aux bonnes pratiques de dispensation des m\u00e9dicaments dans les pharmacies d\u2019officine, les pharmacies mutualistes et les pharmacies de secours mini\u00e8res, mentionn\u00e9es \u00e0 l\u2019article L. 5121-5 du code de la sant\u00e9 publique. Journal Officiel du 1er d\u00e9cembre 2016. Available online: https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000033507633\/. (accessed 5th July, 2025)."},{"issue":"2","key":"3413_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/pharmacy8020089","volume":"8","author":"C Mongaret","year":"2020","unstructured":"Mongaret C, Aubert L, Lestrille A, Albaut V, Kreit P, Herlem E, Noel N, Tour\u00e9 F, Lallier F, Slimano F. The Role of Community Pharmacists in the Detection of Clinically Relevant Drug-Related Problems in Chronic Kidney Disease Patients. Pharm (Basel). 2020;8(2):89. https:\/\/doi.org\/10.3390\/pharmacy8020089.","journal-title":"Pharm (Basel)"},{"issue":"1","key":"3413_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-9560-11-21","volume":"11","author":"MH Prins","year":"2013","unstructured":"Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. EINSTEIN Investigators. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013;11(1):21. https:\/\/doi.org\/10.1186\/1477-9560-11-21.","journal-title":"Thromb J"},{"key":"3413_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/bmj.316.7130.549","volume":"316","author":"SM Kerry","year":"1998","unstructured":"Kerry SM, Bland JM. Statistics notes: Sample size in cluster randomisation. BMJ. 1998;316:549. https:\/\/doi.org\/10.1136\/bmj.316.7130.549.","journal-title":"BMJ"},{"issue":"9","key":"3413_CR12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","volume":"8","author":"F Rodeghiero","year":"2010","unstructured":"Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D, ISTH\/SSC joint VWF and Perinatal\/Pediatric Hemostasis Subcommittees Working Group. ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063\u20135. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03975.x.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3413_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneph.2018.19","volume":"14","author":"TS Potpara","year":"2018","unstructured":"Potpara TS, Ferro CJ, Lip GYH. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nat Rev Nephrol. 2018;14(5):337\u201351. https:\/\/doi.org\/10.1038\/nrneph.2018.19.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"3413_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/10600280221129831","volume":"57","author":"G Givens","year":"2023","unstructured":"Givens G, Neu D, Marler J. The Risk of Major Bleeding With Apixaban Administration in Patients With Acute Kidney Injury. Ann Pharmacother. 2023;57(7):795\u2013802. https:\/\/doi.org\/10.1177\/10600280221129831.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"3413_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ejh.13208","volume":"102","author":"J Weber","year":"2019","unstructured":"Weber J, Olyaei A, Shatzel J. The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature. Eur J Haematol. 2019;102(4):312\u20138. https:\/\/doi.org\/10.1111\/ejh.13208.","journal-title":"Eur J Haematol"},{"key":"3413_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/TCRM.S88911","volume":"13","author":"KC Willett","year":"2017","unstructured":"Willett KC, Morrill AM. Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence. Ther Clin Risk Manag. 2017;13:447\u201354. https:\/\/doi.org\/10.2147\/TCRM.S88911.","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"3413_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MNH.0000000000000634","volume":"29","author":"TA Mavrakanas","year":"2020","unstructured":"Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020;29(5):489\u201396. https:\/\/doi.org\/10.1097\/MNH.0000000000000634.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"3413_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/bcp.15017","volume":"88","author":"S Moudallel","year":"2022","unstructured":"Moudallel S, Cornu P, Dupont A, Steurbaut S. Determinants for under- and overdosing of direct oral anticoagulants and physicians\u2019 implementation of clinical pharmacists\u2019 recommendations. Br J Clin Pharmacol. 2022;88(2):753\u201363. https:\/\/doi.org\/10.1111\/bcp.15017.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3413_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.ajkd.2017.05.008","volume":"70","author":"L Lalonde","year":"2017","unstructured":"Lalonde L, Quintana-B\u00e1rcena P, Lord A, Bell R, Cl\u00e9ment V, Daigneault AM, Legris M\u00c8, Letendre S, Mouchbahani M, Jouini G, Azar J, Martin \u00c9, Berbiche D, Beaulieu S, Beaunoyer S, Bertin \u00c9, Bouvrette M, Charbonneau-S\u00e9guin N, Desrochers JF, Desforges K, Dumoulin-Charette A, Dupuis S, El Bouchikhi M, Forget R, Guay M, Lemieux JP, Morin-B\u00e9langer C, No\u00ebl I, Ricard S, Sauv\u00e9 P, Ste-Marie Paradis F. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial. Am J Kidney Dis. 2017;70(3):386\u201396. https:\/\/doi.org\/10.1053\/j.ajkd.2017.05.008.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3413_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12882-024-03829-y","volume":"25","author":"JA Wilson","year":"2024","unstructured":"Wilson JA, Ratajczak N, Halliday K, Battistella M, Naylor H, Sheffield M, Marin JG, Pitman J, Kennie-Kaulbach N, Trenaman S, Gillis L. Medications for community pharmacists to dose adjust or avoid to enhance prescribing safety in individuals with advanced chronic kidney disease: a scoping review and modified Delphi. BMC Nephrol. 2024;25(1):386. https:\/\/doi.org\/10.1186\/s12882-024-03829-y.","journal-title":"BMC Nephrol"},{"issue":"5","key":"3413_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/17151635231176530","volume":"156","author":"J Tran","year":"2023","unstructured":"Tran J, Shaffelburg C, Phelan E, Neville H, Lively A, Poyah P, Tennankore K, More K, Soroka S, Harpell D, Wilson JA. Community pharmacists\u2019 perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains framework. Can Pharm J (Ott). 2023;156(5):272\u201381. https:\/\/doi.org\/10.1177\/17151635231176530.","journal-title":"Can Pharm J (Ott)"},{"issue":"6","key":"3413_CR22","doi-asserted-by":"publisher","first-page":"e034674","DOI":"10.1136\/bmjopen-2019-034674","volume":"10","author":"L Zekan","year":"2020","unstructured":"Zekan L, Mestrovic A, Perisin AS, Bukic J, Leskur D, Rusic D, Modun D. Improving community pharmacists\u2019 clinical knowledge to detect and resolve drug-related problems in Croatia: a before\/after survey study investigating the efficacy of an educational intervention. BMJ Open. 2020;10(6):e034674. https:\/\/doi.org\/10.1136\/bmjopen-2019-034674.","journal-title":"BMJ Open"},{"issue":"2","key":"3413_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40264-015-0370-0","volume":"39","author":"TH Vo","year":"2016","unstructured":"Vo TH, Charpiat B, Catoire C, Juste M, Roubille R, Rose FX, Chanoine S, Bosson JL, Conort O, Allenet B, Bedouch P. Working Group Standardizing and Demonstrating the Value of Clinical Pharmacy Activities of the French Society for Clinical Pharmacy. Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review. Drug Saf. 2016;39(2):131\u201346. https:\/\/doi.org\/10.1007\/s40264-015-0370-0.","journal-title":"Drug Saf"},{"issue":"4","key":"3413_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/ejhpharm-2020-002642","volume":"28","author":"HT Vo","year":"2021","unstructured":"Vo HT, Charpiat B, Chanoine S, Juste M, Roubille R, Rose FX, Conort O, Allenet B, Bedouch P. Working Group Valorization of Pharmacist Interventions of the French Society of Clinical Pharmacy. CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists\u2019 interventions. Eur J Hosp Pharm. 2021;28(4):193\u2013200. https:\/\/doi.org\/10.1136\/ejhpharm-2020-002642.","journal-title":"Eur J Hosp Pharm"},{"key":"3413_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/JMDH.S337172","volume":"15","author":"LM D\u2019Arrietta","year":"2022","unstructured":"D\u2019Arrietta LM, Vangaveti VN, Crowe MJ, Malau-Aduli BS. Rethinking Health Professionals\u2019 Motivation to Do Research: A Systematic Review. J Multidiscip Healthc. 2022;15:185\u2013216. https:\/\/doi.org\/10.2147\/JMDH.S337172.","journal-title":"J Multidiscip Healthc"},{"issue":"2","key":"3413_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4321\/s1886-36552007000200002","volume":"5","author":"C Armour","year":"2007","unstructured":"Armour C, Brillant M, Krass I. Pharmacists\u2019 views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharm Pract (Granada). 2007;5(2):59\u201366. https:\/\/doi.org\/10.4321\/s1886-36552007000200002.","journal-title":"Pharm Pract (Granada)"},{"issue":"4","key":"3413_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/ijpp.12409","volume":"26","author":"MA De Vera","year":"2018","unstructured":"De Vera MA, Campbell NKJ, Chhina H, Galo JS, Marra C. Practical strategies and perceptions from community pharmacists following their experiences with conducting pharmacy practice research: a qualitative content analysis. Int J Pharm Pract. 2018;26(4):302\u20139. https:\/\/doi.org\/10.1111\/ijpp.12409.","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"3413_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ijpp.12518","volume":"27","author":"P Frisk","year":"2019","unstructured":"Frisk P, Holtendal C, Bastholm-Rahmner P, Sporrong SK. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research. Int J Pharm Pract. 2019;27(4):346\u201354. https:\/\/doi.org\/10.1111\/ijpp.12518.","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"3413_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/ijpp.12522","volume":"27","author":"E Kuipers","year":"2019","unstructured":"Kuipers E, Wensing M, De Smet PAGM, Teichert M. Barriers and facilitators for community pharmacists\u2019 participation in pharmacy practice research: a survey. Int J Pharm Pract. 2019;27(4):399\u2013402. https:\/\/doi.org\/10.1111\/ijpp.12522.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"3413_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12875-023-02163-w","volume":"24","author":"A Piraux","year":"2023","unstructured":"Piraux A, Angibaud M, Nizet P, Navas D, Sallenave-Namont C, Prot-Labarthe S, Huon JF. Factors influencing French community pharmacists\u2019 willingness to participate in research projects: a mixed method study. BMC Prim Care. 2023;24(1):229. https:\/\/doi.org\/10.1186\/s12875-023-02163-w.","journal-title":"BMC Prim Care"},{"issue":"2","key":"3413_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jcpt.12642","volume":"43","author":"TH Vo","year":"2018","unstructured":"Vo TH, Bardet JD, Charpiat B, Leyrissoux C, Gravoulet J, Allenet B, Conort O, Bedouch P. Validation of a tool for reporting pharmacists\u2019 interventions in everyday community pharmacy. J Clin Pharm Ther. 2018;43(2):240\u20138. https:\/\/doi.org\/10.1111\/jcpt.12642.","journal-title":"J Clin Pharm Ther"},{"key":"3413_CR32","doi-asserted-by":"publisher","unstructured":"Chan YH, Chao TF, Lee HF, Yeh YH, Yeh CH, Huang YC, Chang SH, Kuo CT, Lip GYH, Chen SA. Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes. J Am Coll Cardiol. 2020;76(15):1808\u20131810. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.025. PMID: 33032742.","DOI":"10.1016\/j.jacc.2020.08.025"},{"key":"3413_CR33","unstructured":"Association des pharmaciens des \u00e9tablissements de sant\u00e9 du Qu\u00e9bec. Guide d\u2019exercice pour les pharmaciens des \u00e9tablissements de sant\u00e9 du Qu\u00e9bec. Loi 41. F\u00e9vrier 2016. Available online: https:\/\/www.google.com\/url?sa=t&source=web&rct=j&opi=89978449&url=https:\/\/www.apesquebec.org\/system\/files\/2023-12\/20160224_guide_l41.pdf&ved=2ahUKEwiA7rrOve6NAxXmL_sDHcElFYQQFnoECBUQAQ&usg=AOvVaw2G_BUde6wpOS92CKXQ2DH8. (accessed 26th June, 2025)."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-026-03413-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03413-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03413-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:21:16Z","timestamp":1786422076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-026-03413-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3413"],"URL":"https:\/\/doi.org\/10.1186\/s12875-026-03413-3","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This protocol was approved by the Ethics Committee of Poitiers Ouest III (09.26.2024) and by the\n                      Commission Nationale de l\u2019Informatique et des Libert\u00e9s\n                      (12.05.2024). The protocol will be conducted according to the principles of the Declaration of Helsinki and in line with the Guidelines for Good Clinical Practice. The trial is registered with ClinicalTrials.gov under the identifier NCT06739603 (first registered December 17th, 2024). The consent to participate will be obtained written from patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}